Cargando…
Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study
The aim of this study was to evaluate long-term survival and risk factors associated with multidrug-resistant tuberculosis (MDR-TB) patient survival in Central China. Between December 2006 and June 2011, incident and retreatment adult MDR-TB patients were enrolled in the present study. Cox proportio...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078509/ https://www.ncbi.nlm.nih.gov/pubmed/32070443 http://dx.doi.org/10.1017/S0950268820000485 |
_version_ | 1783507634735808512 |
---|---|
author | Wang, Jianjie Zhou, Meilan Chen, Zi Chen, Cong Wu, Gang Zuo, Yingping Ren, Xin Chen, Zhuan Wang, Weihua Pang, Yu |
author_facet | Wang, Jianjie Zhou, Meilan Chen, Zi Chen, Cong Wu, Gang Zuo, Yingping Ren, Xin Chen, Zhuan Wang, Weihua Pang, Yu |
author_sort | Wang, Jianjie |
collection | PubMed |
description | The aim of this study was to evaluate long-term survival and risk factors associated with multidrug-resistant tuberculosis (MDR-TB) patient survival in Central China. Between December 2006 and June 2011, incident and retreatment adult MDR-TB patients were enrolled in the present study. Cox proportional hazard regression analysis was used to evaluate the risk factors affecting survival. The total follow-up period was 270 person-years (PY) for 356 MDR-TB cases in Wuhan. Of the 356 cases, 103 patients died, yielding an average case fatality rate of 381.2 per 1000 TB patients per year. Using adjusted Cox regression analysis, older age (adjusted hazard ratio (aHR) >3.0 starting from 30 years) and low education level (primary and middle school; aHR 1.67 (95% CI 1.01–2.77)) were independently associated with lower survival. Diabetes mellitus profoundly affected the survival of MDR-TB patients (aHR 1.95 (95% CI 1.30–2.93)). Our data demonstrate that coexistent diabetes significantly and negatively impacted MDR-TB patient survival. In addition, MDR-TB patients aged 60 years or older exhibited a greater risk of mortality during follow-up. Our findings emphasise that MDR-TB patients with comorbidities that increase their risk of death require additional medical interventions to reduce mortality. |
format | Online Article Text |
id | pubmed-7078509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-70785092020-03-23 Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study Wang, Jianjie Zhou, Meilan Chen, Zi Chen, Cong Wu, Gang Zuo, Yingping Ren, Xin Chen, Zhuan Wang, Weihua Pang, Yu Epidemiol Infect Original Paper The aim of this study was to evaluate long-term survival and risk factors associated with multidrug-resistant tuberculosis (MDR-TB) patient survival in Central China. Between December 2006 and June 2011, incident and retreatment adult MDR-TB patients were enrolled in the present study. Cox proportional hazard regression analysis was used to evaluate the risk factors affecting survival. The total follow-up period was 270 person-years (PY) for 356 MDR-TB cases in Wuhan. Of the 356 cases, 103 patients died, yielding an average case fatality rate of 381.2 per 1000 TB patients per year. Using adjusted Cox regression analysis, older age (adjusted hazard ratio (aHR) >3.0 starting from 30 years) and low education level (primary and middle school; aHR 1.67 (95% CI 1.01–2.77)) were independently associated with lower survival. Diabetes mellitus profoundly affected the survival of MDR-TB patients (aHR 1.95 (95% CI 1.30–2.93)). Our data demonstrate that coexistent diabetes significantly and negatively impacted MDR-TB patient survival. In addition, MDR-TB patients aged 60 years or older exhibited a greater risk of mortality during follow-up. Our findings emphasise that MDR-TB patients with comorbidities that increase their risk of death require additional medical interventions to reduce mortality. Cambridge University Press 2020-02-19 /pmc/articles/PMC7078509/ /pubmed/32070443 http://dx.doi.org/10.1017/S0950268820000485 Text en © Beijing Chest Hospital 2020 http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Paper Wang, Jianjie Zhou, Meilan Chen, Zi Chen, Cong Wu, Gang Zuo, Yingping Ren, Xin Chen, Zhuan Wang, Weihua Pang, Yu Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study |
title | Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study |
title_full | Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study |
title_fullStr | Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study |
title_full_unstemmed | Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study |
title_short | Survival of patients with multidrug-resistant tuberculosis in Central China: a retrospective cohort study |
title_sort | survival of patients with multidrug-resistant tuberculosis in central china: a retrospective cohort study |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078509/ https://www.ncbi.nlm.nih.gov/pubmed/32070443 http://dx.doi.org/10.1017/S0950268820000485 |
work_keys_str_mv | AT wangjianjie survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy AT zhoumeilan survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy AT chenzi survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy AT chencong survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy AT wugang survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy AT zuoyingping survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy AT renxin survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy AT chenzhuan survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy AT wangweihua survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy AT pangyu survivalofpatientswithmultidrugresistanttuberculosisincentralchinaaretrospectivecohortstudy |